MEETINGS - DiaBioTech 2004 (Italy) October 2004:
This article was originally published in Clinica
Executive Summary
Italy's leading medical technology meeting, DiaBioTech 2004, will be held at the Sala Capranica in Rome on October 12. For the first time, the event will comprise a conference on medical technology policy, as opposed to an exhibition-centred event. The organisers, Italian biomedical and diagnostics industry association Assobiomedica, have moved the biannual event from its previous venues in northern Italy to "raise the voice of Italy's healthcare needs closer to government". For further details contact Assobiomedica, Segreteria Scientifica e Organizzativa, Via Giovanni da Procida 11, 20149 Milano, Italy; tel: + 39 02 34 53 11 65; fax: + 39 02 34 59 20 72; e-mail: [email protected] www.assobiomedica.it
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.